Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Neonatal immune-tolerance in mice does not prevent xenograft rejection.

Mattis VB, Wakeman DR, Tom C, Dodiya HB, Yeung SY, Tran AH, Bernau K, Ornelas L, Sahabian A, Reidling J, Sareen D, Thompson LM, Kordower JH, Svendsen CN.

Exp Neurol. 2014 Apr;254:90-8. doi: 10.1016/j.expneurol.2014.01.007. Epub 2014 Jan 16.

2.

Implantation of undifferentiated and pre-differentiated human neural stem cells in the R6/2 transgenic mouse model of Huntington's disease.

El-Akabawy G, Rattray I, Johansson SM, Gale R, Bates G, Modo M.

BMC Neurosci. 2012 Aug 9;13:97. doi: 10.1186/1471-2202-13-97.

3.

Long-term survival of mouse corpus callosum grafts in neonatal rat recipients, and the effect of host sensitization.

Pollack IF, Lee LH, Zhou HF, Lund RD.

J Neurosci Res. 1992 Jan;31(1):33-45.

PMID:
1613822
4.

Novel therapies in the search for a cure for Huntington's disease.

Beal MF, Hantraye P.

Proc Natl Acad Sci U S A. 2001 Jan 2;98(1):3-4. No abstract available.

5.

Single-cell suspension methodology favors survival and vascularization of fetal striatal grafts in the YAC128 mouse model of Huntington's disease.

Cisbani G, Saint-Pierre M, Cicchetti F.

Cell Transplant. 2014;23(10):1267-78. doi: 10.3727/096368913X668636. Epub 2013 Jun 17.

PMID:
23768945
6.

Pancreatic islet xenograft survival in mice is extended by a combination of alpha-1-antitrypsin and single-dose anti-CD4/CD8 therapy.

Ashkenazi E, Baranovski BM, Shahaf G, Lewis EC.

PLoS One. 2013 May 22;8(5):e63625. doi: 10.1371/journal.pone.0063625. Print 2013.

9.

Encapsulated piscine (tilapia) islets for diabetes therapy: studies in diabetic NOD and NOD-SCID mice.

Safley SA, Cui H, Cauffiel SM, Xu BY, Wright JR Jr, Weber CJ.

Xenotransplantation. 2014 Mar-Apr;21(2):127-39. doi: 10.1111/xen.12086. Epub 2014 Mar 17.

PMID:
24635017
10.

Treatment of rat hemiparkinson model with xenogeneic neural transplantation: tolerance induction by anti-T-cell antibodies.

Okura Y, Tanaka R, Ono K, Yoshida S, Tanuma N, Matsumoto Y.

J Neurosci Res. 1997 Jun 1;48(5):385-96.

PMID:
9185663
11.

Allogeneic versus xenogeneic immune reaction to bioengineered skin grafts.

Erdag G, Morgan JR.

Cell Transplant. 2004;13(6):701-12.

PMID:
15648740
12.
13.

Different immune effects on cardiac allografts and xenografts induced by neonatal intrathymic inoculation with allogeneic and xenogeneic antigens.

Shen Z, Pelletier S, Mohiuddin M, Yokoyama H, Reiss GR, DiSesa VJ.

J Heart Lung Transplant. 1996 Oct;15(10):1034-8.

PMID:
8913921
14.

Rejection triggers liver transplant tolerance: Involvement of mesenchyme-mediated immune control mechanisms in mice.

Morita M, Joyce D, Miller C, Fung JJ, Lu L, Qian S.

Hepatology. 2015 Sep;62(3):915-31. doi: 10.1002/hep.27909. Epub 2015 Jul 30.

15.

Genetic manipulations of mutant huntingtin in mice: new insights into Huntington's disease pathogenesis.

Lee CY, Cantle JP, Yang XW.

FEBS J. 2013 Sep;280(18):4382-94. doi: 10.1111/febs.12418. Epub 2013 Jul 31. Review.

16.

Time limited immunomodulatory functions of transplanted neural precursor cells.

Fainstein N, Einstein O, Cohen ME, Brill L, Lavon I, Ben-Hur T.

Glia. 2013 Feb;61(2):140-9. doi: 10.1002/glia.22420. Epub 2012 Sep 21.

PMID:
23001547
17.

Tolerance of T-independent xeno-antibody responses in the hamster-to-rat xenotransplantation model is species-restricted but not tissue-specific.

Chong AS, Ma LL, Yin D, Blinder L, Shen J, Williams JW.

Xenotransplantation. 2000 Feb;7(1):48-57.

PMID:
10809057
18.

Immune reactions after myoblast transplantation in mouse muscles.

Labrecque C, Roy R, Tremblay JP.

Transplant Proc. 1992 Dec;24(6):2889-92. No abstract available.

PMID:
1465985
19.

Partial resistance to malonate-induced striatal cell death in transgenic mouse models of Huntington's disease is dependent on age and CAG repeat length.

Hansson O, Castilho RF, Korhonen L, Lindholm D, Bates GP, Brundin P.

J Neurochem. 2001 Aug;78(4):694-703.

20.

hESC-derived neural progenitors prevent xenograft rejection through neonatal desensitisation.

Heuer A, Kirkeby A, Pfisterer U, J├Ânsson ME, Parmar M.

Exp Neurol. 2016 Aug;282:78-85. doi: 10.1016/j.expneurol.2016.05.027. Epub 2016 May 25.

Supplemental Content

Support Center